1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Robert Mack, M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2 Riboflavin 0.1% ophthalmic solution, CCL-VARIO UV lamp, CCL-VARIO at 18 mW/cm2 - Keratoconus, Corneal Ectasia | Phase 1 | Unknown | Robert Mack, M.D. | 100 | 2013-10-01 | 2015-12-14 |
Dilatation, Pathologic (1) · Keratoconus (1)
Chromatin Immunoprecipitation Sequencing (1) · Ophthalmic Solutions (1) · Riboflavin (1)
United States (1)